中央纪委国家监委网站 曹溢 近日，中央纪委国家监委驻国家卫生健康委纪检监察组与国家卫生健康委党组联合印发《关于对卫生健 康国家科技重大项目加强纪检监察监督的实施办法》，聚焦国家卫生健康委作为主责单位的国家科技重 大专项、国家重点研发计划重点专项等项目，强化纪检监察监督。 卫生健康科技创新是建设科技强国的重要内容，是保障人民健康的迫切需求，必须放到优先发展位置， 加强战略布局，强化监督保障。 "随着党和国家重视程度的提高，卫生健康国家科技重大项目财政投入不断加大，必须紧盯项目实施中 的廉洁风险，不断加强对卫生健康科研管理工作的监督。"驻国家卫生健康委纪检监察组有关负责同志 表示。 此次出台的《实施办法》贯彻落实二十届中央纪委决策部署，紧密结合卫生健康工作实际，从卫生健康 国家科技重大项目指南形成、立项评审、过程管理、绩效评价和验收及成果转化等关键环节，以及资金 使用管理、专家使用管理等入手，采取参加会议、会商调度、听取汇报、个别谈话、查阅资料、沟通情 况、实地督查、查办案件等方式，开展全链条、嵌入式、穿透式监督。 记者注意到，《实施办法》特别强调科研诚信建设和廉政（洁）建设。明确规定，驻国家卫生健康委纪 检监察 ...

Core Insights - The "14th Five-Year Plan" period has seen significant advancements in health technology innovation in China, with a focus on new drug and vaccine development, medical device innovation, and high-level disease prevention and treatment solutions [1][2][3] Group 1: New Drug and Vaccine Development - China's share of new drugs in global research exceeds 20%, ranking second globally, with several innovative domestic drugs like Sugli monoclonal antibody and Enzalutamide receiving approval [1] - The domestically developed HPV vaccine has improved accessibility and affordability, with the nine-valent HPV vaccine recently launched for broader immunization options for women [1] Group 2: Medical Device Innovation - The domestically developed photon counting CT has improved spatial resolution by 2-3 times compared to traditional CT, with faster scanning speeds and significantly reduced radiation doses [2] - Successful development of orthopedic surgical robots and endoscopic soft tissue surgical robots has enhanced surgical precision and reduced patient trauma [2] - High-end medical equipment such as ECMO, artificial hearts, and proton heavy ion therapy devices have been independently developed and are now in clinical use, improving patient access and outcomes [2] Group 3: High-Level Disease Prevention and Treatment Solutions - Research supported by national technology initiatives has increased the treatment efficacy for difficult-to-treat metastatic colorectal cancer from 13% to 44%, with a 61% extension in progression-free survival [3] - The average time for patients to receive thrombolytic therapy for acute stroke has been reduced from 60 minutes to under 30 minutes, significantly enhancing treatment effectiveness [3] - Development of a diagnostic and treatment system for systemic lupus erythematosus has achieved precise prediction and assessment of disease progression, establishing a personalized treatment model that is internationally leading [3]